Jeremy Grantham co-founded the investment firm known as GMO.
Grantham, Mayo, Van Otterloo & Co. LLC Holdings · Q1 2026
Estimated gain compares the quarter-end mark with a running share-weighted mean of covered-snapshot and add-quarter mean prices. Holdings with incomplete basis or price coverage are excluded.
| Stock | % | Avg. buy price | Estimated gain | Quarter-end price | Last transaction | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Avg. buy price
$521.88
Estimated gain+182.1%Quarter-end price
$1,472.41
Last transaction
Reduced· Q1 2026Sold 9.3% of shares
|
|
1.7% | $521.88 | +182.1% | $1,472.41 | Reduced· Q1 2026Sold 9.3% of shares | |||||
|
Avg. buy price
$75.74
Estimated gain+171.8%Quarter-end price
$205.87
Last transaction
Reduced· Q1 2026Sold 26.1% of shares
|
|
3.8% | $75.74 | +171.8% | $205.87 | Reduced· Q1 2026Sold 26.1% of shares | |||||
|
Avg. buy price
$45.02
Estimated gain+167.7%Quarter-end price
$120.55
Last transaction
Reduced· Q1 2026Sold 3.4% of shares
|
|
0.1% | $45.02 | +167.7% | $120.55 | Reduced· Q1 2026Sold 3.4% of shares | |||||
|
Avg. buy price
$112.78
Estimated gain+151.6%Quarter-end price
$283.77
Last transaction
Added· Q1 2026Increased shares by 6.2%
|
|
0.2% | $112.78 | +151.6% | $283.77 | Added· Q1 2026Increased shares by 6.2% | |||||
|
Avg. buy price
$364.18
Estimated gain+132.3%Quarter-end price
$845.99
Last transaction
Reduced· Q1 2026Sold 56.3% of shares
|
|
0.0% | $364.18 | +132.3% | $845.99 | Reduced· Q1 2026Sold 56.3% of shares | |||||
|
Avg. buy price
$82.34
Estimated gain+118.6%Quarter-end price
$180.00
Last transaction
Reduced· Q1 2026Sold 30.0% of shares
|
|
0.0% | $82.34 | +118.6% | $180.00 | Reduced· Q1 2026Sold 30.0% of shares | |||||
|
Avg. buy price
$106.73
Estimated gain+116.6%Quarter-end price
$231.21
Last transaction
Reduced· Q1 2026Sold 41.1% of shares
|
|
0.0% | $106.73 | +116.6% | $231.21 | Reduced· Q1 2026Sold 41.1% of shares | |||||
|
Avg. buy price
$132.29
Estimated gain+112.7%Quarter-end price
$281.41
Last transaction
Added· Q1 2026Increased shares by 3.4%
|
|
5.1% | $132.29 | +112.7% | $281.41 | Added· Q1 2026Increased shares by 3.4% | |||||
|
Avg. buy price
$31.22
Estimated gain+112.5%Quarter-end price
$66.33
Last transaction
Reduced· Q1 2026Sold 1.3% of shares
|
|
0.0% | $31.22 | +112.5% | $66.33 | Reduced· Q1 2026Sold 1.3% of shares | |||||
|
Avg. buy price
$82.11
Estimated gain+111.6%Quarter-end price
$173.72
Last transaction
Reduced· Q1 2026Sold 14.3% of shares
|
|
0.0% | $82.11 | +111.6% | $173.72 | Reduced· Q1 2026Sold 14.3% of shares | |||||
|
Avg. buy price
$258.99
Estimated gain+109.7%Quarter-end price
$543.12
Last transaction
Reduced· Q1 2026Sold 63.0% of shares
|
|
0.0% | $258.99 | +109.7% | $543.12 | Reduced· Q1 2026Sold 63.0% of shares | |||||
|
Avg. buy price
$14.66
Estimated gain+108.3%Quarter-end price
$30.54
Last transaction
Reduced· Q1 2026Sold 85.4% of shares
|
|
0.0% | $14.66 | +108.3% | $30.54 | Reduced· Q1 2026Sold 85.4% of shares | |||||
|
Avg. buy price
$78.97
Estimated gain+102.2%Quarter-end price
$159.70
Last transaction
Reduced· Q1 2026Sold 2.3% of shares
|
|
1.5% | $78.97 | +102.2% | $159.70 | Reduced· Q1 2026Sold 2.3% of shares | |||||
|
Avg. buy price
$56.16
Estimated gain+102.0%Quarter-end price
$113.42
Last transaction
Reduced· Q1 2026Sold 4.0% of shares
|
|
0.2% | $56.16 | +102.0% | $113.42 | Reduced· Q1 2026Sold 4.0% of shares | |||||
|
Avg. buy price
$146.56
Estimated gain+100.7%Quarter-end price
$294.16
Last transaction
Reduced· Q1 2026Sold 5.2% of shares
|
|
0.1% | $146.56 | +100.7% | $294.16 | Reduced· Q1 2026Sold 5.2% of shares | |||||
L
Lam Research Corporation (LRCX)
−$546M
W
Wells Fargo & Company (WFC)
−$453M
P
Permian Resources Corporation (PR)
−$229M
E
Elevance Health Inc. (ELV)
−$195M
N
NVIDIA Corporation (NVDA)
−$97M
K
KLA Corporation (KLAC)
−$70M
D
Darling Ingredients Inc. (DAR)
−$50M
B
British American Tobacco p.l.c. (BTI)
−$45M
M
Mastercard Incorporated (MA)
+$499M
S
Synopsys, Inc. (SNPS)
New+$411M
M
Microsoft Corporation (MSFT)
+$380M
N
Netflix, Inc. (NFLX)
+$353M
C
Cigna Corporation (CI)
+$177M
U
UnitedHealth Group Incorporated (UNH)
+$145M
V
Visa Inc. (V)
+$124M
U
Uber Technologies, Inc. (UBER)
+$119M
W
Weibo Corporation (WB)
Exited−637K
C
Comerica Incorporated (CMA)
Exited−424K
R
REV Group, Inc. (REVG)
Exited−417K
F
Fox Corporation (FOX)
−390K
F
Frontier Communications Parent, Inc. (FYBR)
Exited−386K
R
Dr. Reddy's Laboratories Limited (RDY)
−316K
S
SolarEdge Technologies, Inc. (SEDG)
−306K
V
Vodafone Group Public Limited Company (VOD)
−281K
R
Sunrun Inc. (RUN)
+2.4M
S
Stellantis N.V. (STLA)
+1.5M
B
Banco Bradesco S.A. (BBD)
+1.2M
G
Gerdau S.A. (GGB)
+989K
S
Select Medical Holdings Corporation (SEM)
New+987K
F
Amicus Therapeutics, Inc. (FOLD)
New+941K
C
CEMEX, S.A.B. de C.V. (CX)
+763K
Largest holdings in Q1 2026, sized by their share of the disclosed portfolio. This shows what is owned, not what changed.
Jeremy Grantham co-founded the investment firm known as GMO. This page shows GMO's quarterly Form 13F report of certain United States listed long positions, not Grantham's personal account or every GMO strategy. Cash, short positions, private investments, many derivatives, and trades completed before quarter end may be absent.
SEC filing history for Grantham, Mayo, Van Otterloo & Co. LLC
Profile refreshed July 20, 2026
As of the Q1 2026 filing, Jeremy Grantham's largest disclosed holdings are Microsoft Corporation (MSFT), Alphabet Inc. (GOOGL), Johnson & Johnson (JNJ). The table shows 15 of 628 positions by default, with an exact-count control for the remaining rows. Disclosed shares and values remain visible even when a separate market-price estimate is unavailable.
The biggest disclosed buys in Q1 2026 were Mastercard Incorporated (MA), Synopsys, Inc. (SNPS), Microsoft Corporation (MSFT), based on the Grantham, Mayo, Van Otterloo & Co. LLC 13F filing. New positions are marked "new" in the table above.
The biggest reductions in Q1 2026 were Lam Research Corporation (LRCX), Wells Fargo & Company (WFC), Permian Resources Corporation (PR). The filing comparison contains 104 full exits, summarized in the activity view above.
The latest 13F discloses $39.1B across 628 positions in Q1 2026. 13F filings cover US-listed long positions only; cash and short positions are not disclosed.
Funds file 13Fs up to 45 days after each quarter ends, so this portfolio reflects Q1 2026, the latest disclosed quarter. The filing date is shown with every table.
Non-rejected, non-superseded SEC Form 13F filings for Grantham, Mayo, Van Otterloo & Co. LLC provide the Q1 2026 holdings, disclosed values, and filing date shown here. WhoBought prefers filings whose value units validate and labels a sparse filing when validation is unavailable. Industry labels come from the local company classification record.
Performance uses daily closing prices for holdings with available market-price history. It covers the priced share of disclosed value (82%); holdings without sufficient price history are excluded from the calculation.
Jeremy Grantham is a British investor who co-founded GMO in 1977 and serves as the firm's chief investment strategist.
He expects markets and asset classes that move far above or below their historical norms eventually to move back toward them. GMO uses long-run history when forming asset-allocation views.
He built his reputation by warning about extreme valuations and limiting exposure during the Japanese asset bubble, the technology boom, and the United States housing bubble.
No. Grantham has said that recognizing an overpriced bubble is different from knowing when it will collapse, which he considers impossible to time precisely.
Yes. In 1971 he helped establish one of the earliest index funds at Batterymarch Financial Management, although the idea was unusual at the time and the fund was not successful.
No. It is a filing by GMO, covering only part of the firm's investment activity. It is not Grantham's personal balance sheet.
No. His record includes successful historical warnings and periods when the approach lagged the market, but this holdings page is not a return series and cannot show all of GMO's asset-allocation, short, derivative, or non-US positions.
Grantham and his wife established the Grantham Foundation for the Protection of the Environment in 1997. It has supported climate research and environmental institutions.